Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

No annotations are supplied, so the description carries the full burden. It does disclose a billing behavior (5 free trial calls per signed wallet), which is genuinely useful, but says nothing about output shape, input validation, error behavior, or whether calls beyond the trial are charged.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

The text is short but under-specified rather than concise: a tautological fragment plus an emoji-laden promotional line. No sentence explains the actual operation, so nothing is front-loaded for the agent.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no annotations, no output schema, and 0% parameter coverage, the description would need to carry all semantics for a two-parameter tool. Instead it explains only the free-trial quota, leaving the core contract entirely undocumented.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 0% and the description adds nothing about the two parameters. The names "n" and "count" are ambiguous — n could be a start value, an index, or an upper bound — and the description does not resolve which value counts what.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

"Prime Series: Series of prime" essentially restates the tool name and never states a verb — it is unclear whether it generates, checks, or sums a prime series. With siblings like x402-prime, x402-prime-factors, x402-is-prime, and x402-fibonacci-series, an agent cannot tell what this one produces or how it differs.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

There is no when-to-use guidance, no prerequisites, and no mention of any alternative tool. The only extra text concerns a free trial quota, which is billing information rather than selection guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.